A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Elite Health Systems Inc.
EHSI
$20M
Mkt Cap
$0.90
-3.23%
Elite Health Systems Inc. (EHSI) has a 5-year average return on invested capital (ROIC) of -25.1%. This is below average and may indicate limited pricing power.
Elite Health Systems Inc. (EHSI) has a market capitalization of $20M. It is classified as a small-cap stock.
Elite Health Systems Inc. (EHSI) does not currently pay a regular dividend.
Elite Health Systems Inc. (EHSI) operates in the Services-Specialty Outpatient Facilities, Nec industry, within the Healthcare sector.
Elite Health Systems Inc. (EHSI) generated $-3 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Elite Health Systems Inc. (EHSI) has a debt-to-equity ratio of 0.01. This indicates a conservatively financed balance sheet.
Elite Health Systems Inc. (EHSI) reported earnings per share (EPS) of $-0.35 in its most recent fiscal year.
Elite Health Systems Inc, formerly U.S. NeuroSurgical Holdings, Inc. (“Holdings”) through its wholly-owned subsidiaries, is developing a business to provide Medicare Advantage plans and related services, concentrating initially in California and Nevada. As used herein, unless the context indicates otherwise, the term "Company" and "Registrant" means Elite Health Systems Inc. and its wholly-owned subsidiary, Elite Health Systems Holdings Inc. (“EHSH”), and the wholly-owned subsidiaries of EHSH, U.S. NeuroSurgical Physics, Inc., USN Corona, Inc., Elite Health Plan, Inc. and Elite Health Plan of Nevada, Inc. Elite Health Systems Inc, a Delaware corporation, was formed in July 1993 originally as U.S. NeuroSurgical, Inc (“USN”). On September 3, 2015, pursuant to the Agreement and Plan of Reorganization (the “Merger Agreement”), dated as of September 3, 2015, by and among USN, Holdings and U.S. NeuroSurgical Merger Sub, Inc.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | 0 | 0 | 0 | 1.1M |
| Net Income | -7.8M | -7.8M | -2.1M | -816K | -1.3M | -881K |
| EPS | $-0.35 | $-0.35 | $-0.13 | $-0.17 | $-0.17 | $-0.11 |
| Free Cash Flow | -2.9M | -2.9M | -1.5M | -891K | -1.4M | 174K |
| ROIC | -190.4% | 0.0% | - | -228.9% | -62.7% | -12.6% |
| Gross Margin | - | 0.0% | - | - | - | - |
| Debt/Equity | 0.01 | 0.01 | - | 0.13 | 0.02 | 0.06 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -3.8M | -3.8M | -1.8M | -765K | -1.4M | -88K |
| Operating Margin | 0.0% | - | - | - | - | -8.3% |
| ROE | -146.9% | -164.5% | - | -86.6% | -70.1% | -28.1% |
| Shares Outstanding | 22M | 22M | 16M | 5M | 8M | 8M |
| Metric | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.6M | 3.0M | 3.2M | 3.4M | 3.4M | 3.1M | 3.2M | 1.1M | 0 | 0 | 0 | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 1.2M | 1.2M | 1.3M | 1.3M | 1.3M | 1.2M | 1.2M | 1.1M | 1.4M | 765K | 1.8M | 4.0M | 4.0M |
| EBIT | 736K | 544K | 614K | 688K | 131K | 1.5M | 1.6M | -88K | -1.4M | -765K | -1.8M | -3.8M | -3.8M |
| Op. Margin | 28.2% | 18.3% | 19.1% | 20.2% | 3.8% | 48.5% | 50.9% | -8.3% | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | 561K | 396K | 536K | 538K | -421K | 142K | 533K | -881K | -1.3M | -816K | -2.1M | -7.8M | -7.8M |
| Net Margin | 21.5% | 13.3% | 16.7% | 15.8% | -12.3% | 4.6% | 16.8% | -83.0% | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 218K | 0 | -663K | 0 | 0 | 0 | 315K | 0 | 0 | 4.0M | 4.0M |
| Returns on Capital | |||||||||||||
| ROIC | 9.6% | 6.8% | 14.2% | 47.2% | 2.7% | 47.5% | 54.3% | -12.6% | -62.7% | N/M | N/A | 0.0% | -190.4% |
| ROE | 28.6% | 16.8% | 18.5% | 17.0% | -13.1% | 4.6% | 15.6% | -28.1% | -70.1% | -86.6% | N/A | -164.5% | -146.9% |
| ROA | 7.5% | 5.4% | 6.5% | 6.7% | -6.0% | 2.5% | 11.6% | -22.4% | -49.2% | -53.2% | -72.8% | -142.1% | -117.1% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 951K | 1.2M | 1.9M | 2.3M | 2.3M | 1.5M | 1.1M | 174K | -1.4M | -891K | -1.5M | -2.9M | -2.9M |
| Free Cash Flow | -590K | 817K | 1.9M | 2.3M | 1.7M | 1.5M | 1.1M | 174K | -1.4M | -891K | -1.5M | -2.9M | -2.9M |
| Owner Earnings | 279K | 223K | 855K | 1.2M | 1.3M | 1.5M | 1.1M | 174K | -1.4M | -891K | -1.5M | -3.5M | -3.5M |
| CapEx | 1.5M | 341K | 0 | 46K | 570K | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 7K |
| Maint. CapEx | 672K | 935K | 1.0M | 1.1M | 983K | 0 | 0 | 0 | 0 | 0 | 0 | 6K | 6K |
| Growth CapEx | 869K | 0 | N/A | 0 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 |
| D&A | 672K | 935K | 1.0M | 1.1M | 983K | 0 | 0 | 0 | 0 | 0 | 0 | 6K | 6K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 569K | 569K |
| Debt Repayment | 340K | 803K | 1.0M | 1.0M | 1.1M | 1.4M | 901K | 89K | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 3.4M | 2.5M | -255K | -1.7M | 868K | -203K | -1.8M | -2.0M | -1.5M | -381K | -4.0M | -3.7M | -3.7M |
| Cash & Equiv. | 1.1M | 1.1M | 2.0M | 2.7M | 1.5M | 1.3M | 2.0M | 2.2M | 1.5M | 466K | 4.0M | 3.8M | 3.8M |
| Long-Term Debt | 3.8M | 2.9M | 2.7M | N/A | 988K | 89K | 0 | N/A | N/A | N/A | N/A | N/A | 38K |
| Debt/Equity | 2.79 | 1.98 | 1.27 | 0.30 | 0.79 | 0.36 | 0.05 | 0.06 | 0.02 | 0.13 | N/A | 0.01 | 0.01 |
| Interest Coverage | 4.0 | 3.0 | 3.8 | 4.5 | 1.2 | 16.4 | 64.6 | -29.3 | N/A | -382.5 | N/A | N/A | N/A |
| Equity | 2.0M | 2.4M | 2.9M | 3.4M | 3.0M | 3.2M | 3.7M | 2.6M | 1.2M | 645K | N/A | 5.3M | 5.3M |
| Total Assets | 7.5M | 7.4M | 8.2M | 7.9M | 6.2M | 5.0M | 4.2M | 3.7M | 1.7M | 1.3M | 4.3M | 6.7M | 6.7M |
| Total Liabilities | 5.5M | 5.0M | 5.3M | 4.5M | 3.2M | 1.8M | 487K | 660K | 291K | 676K | N/A | 1.4M | 1.4M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 |
| Retained Earnings | -1.2M | -820K | -284K | 254K | -167K | -25K | 508K | -373K | -1.7M | -2.4M | -4.4M | -12M | -12M |
| Working Capital | 455K | 549K | 1.4M | 2.1M | 2.2M | 1.0M | 2.6M | 1.6M | 1.3M | -80K | 4.2M | 3.1M | 3.1M |
| Current Assets | 1.5M | 1.8M | 2.9M | 3.7M | 4.1M | 2.7M | 3.0M | 2.2M | 1.6M | 527K | 4.2M | 4.5M | 4.5M |
| Current Liabilities | 1.1M | 1.3M | 1.5M | 1.6M | 1.9M | 1.6M | 410K | 626K | 280K | 607K | 94K | 1.3M | 1.3M |
| Per Share Data | |||||||||||||
| EPS | 0.07 | 0.05 | 0.07 | 0.07 | -0.05 | 0.02 | 0.07 | -0.11 | -0.17 | -0.17 | -0.13 | -0.35 | -0.35 |
| Owner EPS | 0.03 | 0.03 | 0.11 | 0.16 | 0.15 | 0.22 | 0.15 | 0.02 | -0.18 | -0.19 | -0.10 | -0.16 | -0.16 |
| Book Value | 0.24 | 0.30 | 0.38 | 0.45 | 0.36 | 0.44 | 0.48 | 0.32 | 0.16 | 0.13 | N/A | 0.24 | 0.24 |
| Cash Flow/Share | 0.12 | 0.15 | 0.24 | 0.31 | 0.27 | 0.22 | 0.15 | 0.02 | -0.18 | -0.19 | -0.10 | -0.13 | -0.35 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 8.0M | 7.9M | 7.7M | 7.7M | 8.4M | 7.1M | 7.6M | 8.0M | 7.9M | 4.8M | 15.8M | 22.3M | 22.3M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | 4.9 | N/A | 10.0 | 3.7 | N/A | N/A | N/A | N/A | N/A | -2.6 |
| P/FCF | N/A | N/A | N/A | 1.1 | 1.0 | 0.9 | 1.8 | 11.0 | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | 2.3 | 8.8 | 0.1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | 0.8 | 0.6 | 0.5 | 0.5 | 0.7 | 0.8 | 16.9 | N/A | N/A | 3.8 |
| Price/Sales | N/A | N/A | N/A | 0.9 | 0.8 | 0.5 | 0.5 | 2.3 | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | 88.1% | 102.0% | 108.9% | 56.4% | 9.1% | -138.2% | -8.2% | -8.8% | N/A | -14.7% |
| Market Cap | 0 | 0 | 0 | 2.6M | 1.7M | 1.4M | 2.0M | 1.9M | 1.0M | 11M | 17M | 0 | 20M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.38 | 0.31 | 0.22 | 0.22 | 0.31 | 0.19 | 0.17 | 0.70 | 0.00 | 0.90 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.34 | 0.20 | 0.20 | 0.26 | 0.24 | 0.13 | 0.51 | 0.80 | 0.00 | 0.90 |
Elite Health Systems Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
At current prices, the estimated annualized return to fair value is -33.2%.
Elite Health Systems Inc. (EHSI) has a return on equity (ROE) of -164.5%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 17 years of financial data for Elite Health Systems Inc. (EHSI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Elite Health Systems Inc. (EHSI) has a book value per share of $0.24, based on its most recent annual SEC filing.
No recent press releases.